XT
SRPT icon

XTX Topco’s Sarepta Therapeutics SRPT Stock Holding History

XTX Topco’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.13M Buy
118,375
+105,151
+795% +$1.99M 0.03% 1056
2026
Q1 		$288K Buy
+13,224
New +$256K 0.01% 2520
2025
Q3 		– Sell
-31,808
Closed -$544K – 3235
2025
Q2 		$544K Buy
+31,808
New +$1.36M 0.02% 1032
2024
Q3 		– Sell
-4,578
Closed -$723K – 2586
2024
Q2 		$723K Buy
+4,578
New +$588K 0.06% 489
2022
Q1 		– Sell
-2,495
Closed -$225K – 933
2021
Q4 		$225K Buy
+2,495
New +$213K 0.13% 324
2021
Q2 		– Sell
-8,643
Closed -$644K – 1076
2021
Q1 		$644K Buy
+8,643
New +$798K 0.31% 44

Other funds holding SRPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

XTX Topco's SRPT Position: Q2 2026 in Review

XTX Topco increased its Sarepta Therapeutics (SRPT) stake by 795% in Q2 2026, buying an estimated $1.99M and bringing the position to 118,375 shares worth $2.13M. The position accounts for 0.03% of the portfolio, ranked #1056.

XTX Topco first reported a position in SRPT in Q1 2021 and has held it in 6 quarters since. 323 funds tracked by Wall St. Rank hold SRPT as of Q2 2026.

  • XTX Topco held 118,375 shares of Sarepta Therapeutics worth $2.13M as of Q2 2026.
  • XTX Topco bought 105,151 Sarepta Therapeutics shares in Q2 2026, an estimated $1.99M.
  • Sarepta Therapeutics made up 0.03% of XTX Topco's portfolio in Q2 2026, its #1056 holding.
  • XTX Topco first reported a position in Sarepta Therapeutics in Q1 2021 and has held it in 6 quarters since.
  • 323 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.